ArticleTropical medicine and infectious disease2023

Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021.

Bolot Kyrbashov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.